- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Vital Images secures stock placement
Minneapolis-based Vital Images has recruited eight accredited institutional investors to purchase 1.5 million shares of common stock at $13.50 per share. The private placement, announced June 2, generated some $19 million after deducting closing costs
Minneapolis-based Vital Images has recruited eight accredited institutional investors to purchase 1.5 million shares of common stock at $13.50 per share. The private placement, announced June 2, generated some $19 million after deducting closing costs and placement fees. U.S. Bancorp Piper Jaffray served as exclusive placement agent for the transaction. Funds will provide the flexibility to expand VI's business through acquisition or other opportunities, according to the company. In weeks prior to the placement, VI stock soared to nearly $18. As of June 5, share price had settled at about $14.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
